← Leaderboards
Calvin J Stephens
Washington University
$82,288
Attributed
$82,288
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $30.7K · FY2016–18$50K$37.5K$25K$12.5K$0
'16
'17
'18
Funding mix
By agency
NIH$82,288 · 1
By mechanism
F31$82,288 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Lee Ratner$26,026,037
- Sean R. Eddy$6,029,858
- Jeffrey H Miner$20,654,870
- Scott J Hultgren$48,876,558
- Jeanne M Nerbonne$23,263,404
Others in their field
Top investigators on “Frequencies”
- Ethan Schreier · Associated Universities, Inc.$206,468,864
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Richard A Gibbs · Baylor College Of Medicine$99,376,162
- Maury Tigner · Cornell University$99,355,712
- Stacey Gabriel · Massachusetts Institute Of Technology$87,638,281
- Arie Kapteyn · Rand Corporation$73,823,224
Research focus
FrequenciesAdenovirusesAdenoviral-MediatedFactor IxAdverse EffectsAffectAnimal ModelAntibody FormationEventBaseBlood Coagulation DisordersCandidate Disease GeneClinical TreatmentCloningClustered Regularly Interspaced Short Palindromic RepeatsCoagulation ProcessCo-InfectionCrispr/Cas TechnologyAdenovirus VectorEndonucleaseDesignDoseEmbryoGene Delivery
Grant awards (3)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery$21,454
F31 · FY2018 · DK · contact PI
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery$30,651
F31 · FY2017 · DK · contact PI
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery$30,183
F31 · FY2016 · DK · contact PI